Atlas Trials

A Study to Investigate the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) as an Adjunctive Therapy in Children and Adults With Lennox-Gastaut Syndrome

Clinical trial NCT03355209 · COMPLETED

Trial details

NCT number
NCT03355209
Sponsor
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Lennox Gastaut Syndrome
Start date
2017-11-27
Primary completion
2024-05-23
Enrollment
296

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.